TX-SNOW-SOFTWARE
10.11.2022 15:01:39 CET | Business Wire | Press release
Snow Software, the global leader in technology intelligence, today announced new and enhanced capabilities to support IT leaders seeking to negotiate better contract terms, lower operating expenses and boost organizational-wide efficiencies during this period of macroeconomic uncertainty. The latest features offer a richer view of an organization’s IT investments and the impact to the business, providing new ways to optimize costs and ensure value of complex technologies like containers and cloud services. Container visibility, one of the newest innovations on the Snow Atlas platform, provides details on applications running in Kubernetes containers to identify cost savings.
“The macroeconomic environment is forcing organizations to seek a deeper understanding of how all areas of their business are performing,” said Sanjay Castelino, Chief Product and Customer Officer at Snow. “With large annual budgets devoted to IT spend, demonstrating return on investment for every technology purchase is vital for CIOs and IT teams. The latest release from Snow not only identifies how technology is used but also offers use cases to support more sustainable IT practices such as understanding the carbon footprint of devices. With IT environments more complex than ever, the intelligence Snow provides serves as the backbone for organizations seeking to get more control over IT spending and risk.”
Gaining Visibility of Container Environments
More than 70% of global organizations will use containerized applications by 2023, according to industry analysts. Widespread use of containers creates new barriers for organizations seeking to understand what is running in a container – let alone control costs.
The new container visibility feature available on Snow Atlas is designed to provide IT teams and IT asset managers (ITAM) details on what applications are running, how many containers are used in their environment, and how long containers have been running. In this release, the capability provides insights into Microsoft, Oracle and Red Hat standard containerized applications running in Kubernetes environments. Container visibility is available for Kubernetes environments running on major cloud services such as Amazon Web Services (AWS) and Microsoft Azure environments. This insight enables IT and ITAM teams to manage cost more efficiently.
Snow is inviting organizations with Kubernetes environments to use the functionality, with general availability of the capability aimed at early 2023.
Empowering ITAM to Partner with FinOps to Manage Rising Cloud Costs
To give a more complete picture of the end-to-end organizational tech stack, the latest release from Snow gives ITAM teams a spend snapshot across AWS and Azure in the terminology and views used by ITAM. With this new service – available to all Snow Atlas customers – ITAM teams have improved views of their organization’s spend profile in public cloud natively within their SAM tool. By building this feature natively within the existing SAM product, Snow makes it easier for ITAM to drive conversations about spend optimization with cloud stakeholders and FinOps teams.
For organizations with more mature cloud practices, FinOps or cloud operations practitioners, Snow Cloud Cost powered by Anodot provides greater depth of visibility, insights and analysis on public cloud spend, controls for budget management and spend allocation, detection of anomalies and recommendations for optimizing spend.
Enabling IT to Build a Sustainable Enterprise
Developing a more sustainable enterprise is a top priority for most CIOs. Snow makes it easier for IT teams to deliver on their sustainability goals. Organizations can leverage existing ITAM data, such as the laptop and desktop details, to assess their sustainability baseline. This sustainability intelligence report from Snow also includes curated information on how many certified sustainable devices exist, the spectrum of energy efficient devices and an evaluation of carbon emission reduction with on-premises to cloud shifts. The data provided by Snow enables CIOs and IT leaders to take proactive measures to actively manage and advance their sustainability initiatives.
Expanded Support to Reduce S/4HANA Migration Risks
With the end of maintenance for Business Suite 7 approaching, the migration to S/4HANA is a strategic imperative for many organizations. Snow is releasing new license intelligence, contract management and management dashboards for Snow Optimizer for SAP® Software to help offer further support with S/4HANA migrations. The new license intelligence capabilities allow organizations to easily simulate alternative license scenarios for both usage and authorization-based licensing, helping them decide on the most efficient and cost-effective migration strategy. In addition, new functionality allows for more transparent and secure management of an organization’s SAP environment by providing insight into license metrics and enhanced controls over contract management.
These new and enhanced capabilities follow several notable product milestones for Snow this year, including a new host of capabilities for Snow Atlas, a new partnership with Anodot to transform cloud cost management, verification on Oracle Database and Database Options and new enhancements for Snow Commander.
For more information or to request a demo, please visit www.snowsoftware.com.
About Snow Software
Snow Software is changing the way organizations understand and manage their technology consumption. Our technology intelligence platform provides comprehensive visibility and contextual insight across software, SaaS, hardware and cloud. With Snow, IT leaders can effectively optimize resources, enhance performance and enable operational agility in a hybrid world. To learn more, visit www.snowsoftware.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221110005344/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
